("
Grant of Options
Details of the options are set out below:
Exercise price: |
1p* |
Exercise period: |
From date of grant to |
*being a premium of 25 per cent. over mid closing price on
The options represent approximately 2.5 per cent. of the Company's issued ordinary share capital.
The table below sets out
|
|
Interest over shares |
3,164,706 |
Interest over options |
6,350,000 |
Interest over warrants |
800,000 |
The issued share capital of the Company comprises 254,367,047 ordinary shares.
Following the grant of the options detailed above, a total of 10,251,398 options and 62,717,950 warrants are outstanding at the date of this notification, representing approximately 28.7 per cent. of the Company's issued ordinary share capital.
The grant of options as set out above (the "Transaction") is deemed to be a related party transaction under the AIM Rules for Companies.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
The Directors of
For further information, please contact:
|
+44 (0) 78 7958 4153 |
James Caithie /
|
+44 (0) 20 7213 0880 |
|
+44 (0) 20 7469 0930 |
This information is provided by RNS, the news service of the